Elligo Health Research Acquires Protenium Clinical Research

January 9, 2019

Applied Clinical Trials

Elligo Health Research, an integrated research organization, has acquired Protenium Clinical Research, an established research group led by Robert Strzinek, Ph.D., D.O. which conducts pharmaceutical studies in a broad range of therapeutic areas. The acquisition will bring the number of patients in Elligo’s Research Ready network to more than one million.

Read the full release here.